Answers are grounded in this paper and cite their sources.
Novel biodegradable membranes show controlled drug release and superior biocompatibility, indicating potential for preventing intrauterine adhesions.
Intrauterine adhesions pose a significant challenge to female fertility, with current treatments showing limited efficacy and safety concerns, including poor biocompatibility and secondary trauma risks. In this work, we present a novel biodegradable bacterial nanocellulose (BC)-based physical barrier that integrates controlled drug release capabilities for preventing intrauterine adhesions. Through TEMPO-mediated oxidation and N-vinyl pyrrolidone grafting, we developed BC membranes exhibiting superior biocompatibility (cell death rate <5%) and selective fibroblast inhibition. The system achieves controlled biodegradation over 14 days while maintaining mechanical integrity (tensile strength >2.0 MPa) and providing sustained β-estradiol release. This approach represents a significant advancement in intrauterine adhesion prevention strategies.
No takes yet. Share an insight, caveat, or question.
Lü et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: